EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2236
https://www.valueinhealthjournal.com/article/S1098-3015(24)02450-1/fulltext
Title :
EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02450-1&doi=10.1016/j.jval.2024.03.2236
First page :
Section Title :
Open access? :
No
Section Order :
10231